Literature DB >> 33548241

A peptide of the amino-terminus of GRK2 induces hypertrophy and yet elicits cardioprotection after pressure overload.

Kamila M Bledzka1, Iyad H Manaserh1, Jessica Grondolsky1, Jessica Pfleger2, Rajika Roy2, Erhe Gao2, J Kurt Chuprun2, Walter J Koch3, Sarah M Schumacher4.   

Abstract

G protein-coupled receptor (GPCR) kinase 2 (GRK2) expression and activity are elevated early on in response to several forms of cardiovascular stress and are a hallmark of heart failure. Interestingly, though, in addition to its well-characterized role in regulating GPCRs, mounting evidence suggests a GRK2 "interactome" that underlies a great diversity in its functional roles. Several such GRK2 interacting partners are important for adaptive and maladaptive myocyte growth; therefore, an understanding of domain-specific interactions with signaling and regulatory molecules could lead to novel targets for heart failure therapy. Herein, we subjected transgenic mice with cardiac restricted expression of a short, amino terminal fragment of GRK2 (βARKnt) to pressure overload and found that unlike their littermate controls or previous GRK2 fragments, they exhibited an increased left ventricular wall thickness and mass prior to cardiac stress that underwent proportional hypertrophic growth to controls after acute pressure overload. Importantly, despite this enlarged heart, βARKnt mice did not undergo the expected transition to heart failure observed in controls. Further, βARKnt expression limited adverse left ventricular remodeling and increased cell survival signaling. Proteomic analysis to identify βARKnt binding partners that may underlie the improved cardiovascular phenotype uncovered a selective functional interaction of both endogenous GRK2 and βARKnt with AKT substrate of 160 kDa (AS160). AS160 has emerged as a key downstream regulator of insulin signaling, integrating physiological and metabolic cues to couple energy demand to membrane recruitment of Glut4. Our preliminary data indicate that in βARKnt mice, cardiomyocyte insulin signaling is improved during stress, with a coordinate increase in spare respiratory activity and ATP production without metabolite switching. Surprisingly, these studies also revealed a significant decrease in gonadal fat weight, equivalent to human abdominal fat, in male βARKnt mice at baseline and following cardiac stress. These data suggest that the enhanced AS160-mediated signaling in the βARKnt mice may ameliorate pathological cardiac remodeling through direct modulation of insulin signaling within cardiomyocytes, and translate these to beneficial effects on systemic metabolism.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  GRK2; Heart failure; Hypertrophy; Physiological; Proteomics

Mesh:

Substances:

Year:  2021        PMID: 33548241      PMCID: PMC8101069          DOI: 10.1016/j.yjmcc.2021.01.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  70 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 2.  The molecular basis for oxidative stress-induced insulin resistance.

Authors:  Joseph L Evans; Betty A Maddux; Ira D Goldfine
Journal:  Antioxid Redox Signal       Date:  2005 Jul-Aug       Impact factor: 8.401

Review 3.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

Review 4.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

Authors:  Frédéric Tremblay; AnneMarie Gagnon; Alain Veilleux; Alexander Sorisky; André Marette
Journal:  Endocrinology       Date:  2004-12-02       Impact factor: 4.736

6.  Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.

Authors:  Liyan Zhang; Jagdip S Jaswal; John R Ussher; Sowndramalingam Sankaralingam; Cory Wagg; Michael Zaugg; Gary D Lopaschuk
Journal:  Circ Heart Fail       Date:  2013-07-16       Impact factor: 8.790

7.  Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation.

Authors:  Hiroyuki Sano; Susan Kane; Eiko Sano; Cristinel P Mîinea; John M Asara; William S Lane; Charles W Garner; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

8.  GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels.

Authors:  Priscila Y Sato; J Kurt Chuprun; Jessica Ibetti; Alessandro Cannavo; Konstantinos Drosatos; John W Elrod; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2015-10-23       Impact factor: 5.000

9.  AS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane.

Authors:  Françoise Koumanov; Judith D Richardson; Beverley A Murrow; Geoffrey D Holman
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

10.  Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes.

Authors:  Laura Trinkle-Mulcahy; Séverine Boulon; Yun Wah Lam; Roby Urcia; François-Michel Boisvert; Franck Vandermoere; Nick A Morrice; Sam Swift; Ulrich Rothbauer; Heinrich Leonhardt; Angus Lamond
Journal:  J Cell Biol       Date:  2008-10-20       Impact factor: 10.539

View more
  3 in total

Review 1.  Emerging therapeutic targets for cardiac hypertrophy.

Authors:  Alexander J Winkle; Drew M Nassal; Rebecca Shaheen; Evelyn Thomas; Shivangi Mohta; Daniel Gratz; Seth H Weinberg; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2022-01-27       Impact factor: 6.902

2.  Cardiac GRK2 and the Communicative Axis Between Heart and Fat.

Authors:  Bradford G Hill
Journal:  JACC Basic Transl Sci       Date:  2022-06-27

3.  A Cardiac Amino-Terminal GRK2 Peptide Inhibits Maladaptive Adipocyte Hypertrophy and Insulin Resistance During Diet-Induced Obesity.

Authors:  Iyad H Manaserh; Kamila M Bledzka; Alex Junker; Jessica Grondolsky; Sarah M Schumacher
Journal:  JACC Basic Transl Sci       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.